CRNC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cerence Inc (CRNC) is not a strong buy at the moment for a beginner investor with a long-term focus. Despite some positive financial growth in revenue and hedge fund interest, the stock's weak technical indicators, declining analyst price targets, insider selling, and lack of strong growth or profitability make it a less compelling investment opportunity currently.
The technical indicators for CRNC are bearish. The MACD is below zero and negatively contracting, RSI is neutral at 42.448, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key resistance levels, with support at 7.44 and resistance at 8.372. Overall, the technical setup does not indicate a strong buy signal.
Revenue increased by 126.10% YoY in Q1
Hedge funds are significantly increasing their positions, with a 348.02% increase in buying activity over the last quarter.
Net income and EPS have dropped significantly YoY (-78.43% and -78.95%, respectively).
Insider selling has increased by 8776.61% over the last month, indicating potential lack of confidence from insiders.
Analysts have lowered price targets recently, citing limited growth and profitability.
Lack of recent news or event-driven catalysts to drive the stock higher.
In Q1 2026, Cerence's revenue grew by 126.10% YoY to $115.08 million, and gross margin improved to 86.33% (up 35.12% YoY). However, net income dropped to -$5.24 million (-78.43% YoY), and EPS fell to -0.12 (-78.95% YoY), reflecting poor profitability despite revenue growth.
Analysts have lowered price targets recently, with Goldman Sachs reducing the target to $8 from $11 and TD Cowen reducing it to $12 from $13. Both firms maintain neutral/hold ratings, citing limited growth, profitability concerns, and a noisy financial outlook.
